AviGate S. Infantis Live Vaccine Gains EMA Approval
The European Medicines Agency's CVMP has recommended the marketing authorization of AviGate S. Infantis, a live vaccine aimed at controlling Salmonella Infantis in poultry.
Editorial Staff
1 min read
Updated in 5 months
The European Medicines Agency (EMA) has taken a significant step in poultry health by issuing a positive recommendation for the marketing authorization of AviGate S. Infantis.
Developed by Huvepharma, this live vaccine is designed to combat Salmonella Infantis, a pathogen that poses serious health risks to poultry.
The recommendation from the EMA's Committee for Veterinary Medicinal Products (CVMP) marks an important milestone in the fight against this bacterial infection, which can affect both animal and human health.